The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2466-2476

  Attema, Joanne L ^a   Reeves, Raymond ^a   Murray, Vincent ^a   Levichkin, Ilya ^a   Temple, Mark D ^a   Tremethick, David J ^a   Shannon, M Frances ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; INTERLEUKIN 2; PROTEIN; PROTEIN HMGA1; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CHROMATIN; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LEUKEMIA CELL LINE; NUCLEOSOME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION;

EID: 0036721705     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2466     Document Type: Article

References (64)

1. Signaling domains of the interleukin 2 receptor
2. Interleukin-2
3. Upstream-downstream: CD28 cosignaling pathways and T cell function
4. Thymic stromal-cell abnormalities and dysregulated T-cell development in IL-2-deficient mice
5. + T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules
6. On the stochastic regulation of interleukin-2 transcription
7. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes
8. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation
9. A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor
10. Regulation of human interleukin-2 gene: Functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes
11. Characterization of antigen receptor response elements within the interleukin-2 enhancer
12. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40
13. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes
14. Nuclear factor of activated T cells contains Fos and Jun
15. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB
16. The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer
17. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation
18. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-ΚB-like response element
19. The architecture of the interleukin-2 promoter: A reflection of T lymphocyte activation
20. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters
21. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells
22. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells
23. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter
24. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites
25. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2
26. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter
27. HMGI/Y proteins: Flexible regulators of transcription and chromatin structure
28. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation
29. Role of chromatin structure in the regulation of transcription by RNA polymerase II
30. Centromeric chromatin: Histone deviants
31. Alteration of nucleosome structure as a mechanism of transcriptional regulation
32. Nucleosome positioning and modification: Chromatin structures that potentiate transcription
33. Rapid and selective re-modeling of a positioned nucleosome during the induction of IL-12 p40 transcription
34. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome
35. In vivo structure of the cell cycle-regulated human cde25C promoter
36. Hormone-induced nucleosome positioning in the MMTV promoter is reversible
37. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors
38. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation
39. Chromatin remodeling of the interleukin-2 gene: Distinct alterations in the proximal versus distal enhancer regions
40. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells
41. In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells
42. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: Both Fos and Jun contact DNA directly
43. Purification and assays for high mobility group HMG-I(Y) protein function
44. Reconstitution of chromatin core particles
45. DNA binding mode of class-IIS restriction endonuclease Fokl revealed by DNA footprinting analysis
46. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free nucleosomal DNA
47. The structure of DNA in a nucleosome
48. Influence of chromatin structure on bleomycin-DNA interactions at base pair resolution in the human β-globin gene cluster
49. Protein-DNA foot-printing of the human epsilon-globin promoter in human intact cells using nitrogen mustard analogues and other DNA-damaging agents
50. Chromatin remodeling, measured by a real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene
51. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative
52. Amplification of bleomycin-induced DNA cleavage at cytosine residues 3′ to GGG sequences by pyrrole triamide
53. Artificial nucleosome positioning sequences
54. DNA and protein determinants of nucleosome positioning on sea urchin 5S rRNA gene sequences in vitro
55. DNA bending and its relation to nucleosome positioning
56. Identification and characterization of genomic nucleosome-positioning sequences
57. DNA sequence-dependent contributions of core histone tails to nucleosome stability: Differential effects of acetylation and proteolytic tail removal
58. The G + C-rich discriminator region of the tyrT promoter antagonises the formation of stable preinitiation complexes
59. A theoretical model for the prediction of sequence-dependent nucleosome thermodynamic stability
60. Nucleosome structural features and intrinsic properties of the TATAAACGCC repeat sequence
61. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor α gene
62. Deficiency of PTEN in Jurkat T cells causes constitutive localisation of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation
63. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling